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The risks of HCV infection among 
Brazilian crack cocaine users: 
incorporating diagnostic test 
uncertainty
Carolina Coutinho1,2, Leonardo S. Bastos3, Jurema Corrêa da Mota1, Lidiane Toledo1, 
Katia Costa1, Neilane Bertoni  4 & Francisco I. Bastos1
Despite the initiative by WHO and other international organizations to eliminate HCV in the medium 
term, hepatitis C infection is still a major public health problem. Even non-injecting drugs users who 
engage in harmful or addictive drug use are at greater risk of acquiring the infection, when compared 
to the general population. This study evaluate risk factors for HCV infection in users of crack/cocaine 
in Brazil, using multilevel models that incorporate variations in the sensitivity and specificity of the 
respective diagnostic tests. The sample included all the participants of a national survey on street crack 
cocaine users with serologically reactive result in the rapid test for the HCV as well as 4 non-reactive 
controls, matched by sex, age category, and major geographic region of residence. Multilevel logistic 
regression models were used, with and without incorporation of the diagnostic test’s sensitivity and 
specificity values. The odds of HCV infection were 85% higher among polydrug users, 7.81 times higher 
among injecting drug users, and 3.69 times higher in those reporting to have genital ulcers. Statistical 
modeling strategies that incorporate the sensitivity and specificity of diagnostic tests in challenging 
settings are useful for studying the association between risk factors and infection status.
Despite undeniable strides in the treatment of hepatitis C infection and the strategy led by the WHO (World 
Health Organization) to eliminate hepatitis B and C by 20301,2, these infections are still a major global pub-
lic health problem, especially hepatitis C, for which no vaccine exists, and for which the existing treatments 
are expensive, although curative. Acute HCV infection is usually asymptomatic, and an estimated 15% to 45% 
infected persons eliminate the virus spontaneously without any treatment. The other cases (55% to 85% of per-
sons) develop chronic HCV infection, and among these, there is a high (15% to 30%) estimated risk of hepatic 
cirrhosis in the absence of therapeutic intervention1. According to the World Health Organization3, approxi-
mately 700 thousand people die per year in the world from complications of HCV infection. Due to the largely 
asymptomatic nature of HCV infection, many HCV-positive individuals are actually unaware of their serological 
status. Others have been diagnosed but are unable to obtain treatment. The lack of a quick and reliable diagnosis 
and the high cost and limited access to new treatments are barriers to the control and elimination of the disease3,4.
Parenteral infection is still the main form of HCV transmission, and an estimated 1.75 million new HCV 
infections occurred in the world in the year 2015 alone5. Persons that use illegal drugs are often exposed to 
increased risk of various infectious diseases, basically due to their behaviors and drug consuming habits, in addi-
tion to the risks and harms associated with the respective self-administration routes6–9. Various studies have 
reported high HCV prevalence rates, especially among people who inject drugs (PWID)10–12. As for non-injecting 
drug users (NIDU), who smoke, inhale, snort, or sniff substances like heroin, [powder] cocaine, and crack 
cocaine, for example, there are reports of higher HCV prevalence rates than in the general population, suggesting 
that there may be some other relevant form of transmission, despite persistent controversies on viral viability in 
1Institute of Scientific and Technological Communication and Information in Health (ICICT), FIOCRUZ, Rio de Janeiro, 
Brazil. 2Program of Epidemiology in Public Health, Sergio Arouca National School of Public Health (ENSP), FIOCRUZ, 
Rio de Janeiro, Brazil. 3Scientific Computing Program, FIOCRUZ, Rio de Janeiro, Brazil. 4Division of Epidemiology, 
National Cancer Institute (INCa), Rio de Janeiro, Brazil. Correspondence and requests for materials should be 
addressed to C.C. (email: coutinho.carol@gmail.com)
Received: 13 July 2018
Accepted: 31 October 2018
Published: xx xx xxxx
OPEN
www.nature.com/scientificreports/
2Scientific RepORTs |           (2019) 9:443  | DOI:10.1038/s41598-018-35657-0
straws and other self-administration paraphernalia in a context in which the risks of sexual transmission may be 
underestimated or imprecisely assessed13–16.
Epidemiological studies that assess risk factors generally use logistic regression and or other statistical mod-
eling strategies to estimate the effect of predictors potentially associated with binary target outcomes (e.g., infec-
tion status). Less bias-prone estimates require consistent information concerning the observed outcome, in this 
case infection status17. Infection status is classically defined as the result of a diagnostic test, which contemplates 
specificity and sensitivity parameters in use-specific contexts18. Thus, the results of these analyses inadvertently 
incorporate the inherent validity (sensitivity and specificity) of these tests and may add bias to the resulting esti-
mates19. A risk factor analysis that incorporates the diagnostic tests’ sensitivity and specificity tends to produce 
less skewed estimates when compared to analyses that fail to consider the respective diagnostic method’s inherent 
uncertainties19. The inherent advantages of including the specificity and sensitivity ranges of a given diagnostic 
test in logistic regression models have been demonstrated by some studies17,20.
The current study thus aims to estimate risk factors for HCV infection in users of crack and/or similar sub-
stances in Brazil, using multilevel logistic regression models that incorporate the diagnostic test’s sensitivity and 
specificity.
Results
Table 1 shows the sample’s distribution by sex and age category. Of the 129 HCV-positive individuals, 98 were 
males (76%), and the majority for both sexes combined were in the 31 to 45-year age category (53.5%). However, 
the sample showed an age profile with slightly older males, in whom individuals from the most prevalent age 
brackets (31 to 45 years and 46 and older) concentrated 85.7% of the cases, while in women the younger age 
brackets were more prevalent, namely 18–30 years and 31–45 years, including 81.7% of the cases in females.
Table 2 shows the data on sociodemographic characteristics, substance use, risk behavior, and symptoms 
consistent with sexually transmitted infections, comparing cases and controls. Polydrug use was more frequent 
among HCV-positive individuals compared to those HCV-negative users (78.3% and 65.9%, respectively). Nearly 
two-thirds (62.7%) of HCV-positive individuals had used crack and/or similar drugs for more than 5 years, a 
statistically higher proportion than among HCV-negative individuals (52.5%). Among HCV-positive individuals, 
Geographic region Sex Age bracket Cases Controls
North
Male
18 to 30 1 4
31 to 45 3 12
46+ 1 4
Female
18 to 30 1 4
31 to 45 1 4
46+ 2 8
Northeast
Male
18 to 30 3 12
31 to 45 13 52
46+ 8 32
Female
18 to 30 0 0
31 to 45 6 24
46+ 0 0
Southeast
Male
18 to 30 1 4
31 to 45 11 44
46+ 6 24
Female
18 to 30 1 4
31 to 45 4 16
46+ 1 6
South
Male
18 to 30 5 20
31 to 45 18 72
46+ 8 32
Female
18 to 30 3 12
31 to 45 4 16
46+ 2 6
Central-West
Male
18 to 30 4 16
31 to 45 6 24
46+ 10 40
Female
18 to 30 2 8
31 to 45 3 12
46+ 1 4
Table 1. Distribution of cases and controls by major geographic region, sex, and age category (matching 
variables). Brazil, 2012.
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40.3% reported having traded sex for drugs or money, compared to 27.5% in HCV-negative individuals, and the 
difference was statistically significant. Just over half (51.9%) of HCV-positive individuals reported having used 
injection drugs some time in life, a significantly higher proportion than the 13.0% in HCV-negative individuals 
(Table 2).
Figure 1 depicts the results of the multilevel logistic regression models, adjusted odds ratios and respective 
95% confidence intervals for data without incorporation of the uncertainty potentially associated with the tests’ 
sensitivity and specificity. Considering the model without incorporation of uncertainty in the outcome, the odds 
of a positive HCV test were 75% higher in polydrug users (OR: 1.75; 95% CI:1.06–2.89), 6.60 higher in individuals 
that reported ever having used injection drugs (OR: 7.60; 95% CI:4.87–11.85), and 2.91 higher for individuals that 
reported genital ulcers (OR: 3.91; 95% CI: 1.29–11.89).
Variables Categories
Cases Controls
p-value*n % n %
Race/color
White 27 21.3 129 25.2
0.631
Black 25 19.7 107 20.9
Brown 70 55.1 262 51.3
Indigenous/Asian-descendant 5 3.9 13 2.5
Schooling
Did not finish any grade 9 7.0 37 7.2
0.890
Primary 89 69.5 362 70.6
Secondary 23 18.0 94 18.3
University 7 5.5 20 3.9
Housing**
Own or family’s apartment/house 33 25.6 182 35.4
0.246
Rented or friends’ apartment/house/room 28 21.7 98 19.1
Temporary housing (boarding house, hotel, shelter, etc.) 8 6.2 20 3.9
Other 5 3.9 14 2.7
Street (homeless) 55 42.6 200 38.9
Main source of income**
Odds jobs 82 65.6 361 70.8
0.568
Regular employment with benefits 18 14.4 55 10.8
Illegal activity 9 7.2 23 4.5
Family/partner 5 4.0 18 3.5
Sex worker 4 3.2 13 2.5
Begging 7 5.6 40 7.8
Polydrug use
Crack /1 illegal drug 28 21.7 176 34.1
0.007
Crack/2 or more illegal drugs 101 78.3 340 65.9
Length of crack use
Up to 5 years 44 37.3 225 47.5
0.047
More than 5 years 74 62.7 249 52.5
Condom use**
Did not have sexual relations in the last 30 days 36 27.9 167 32.4
0.252Failed to use condom at least once 77 59.7 266 51.7
Always used condoms 16 12.4 82 15.9
Trades sex for drugs or money
No 77 59.7 374 72.5
0.005
Yes 52 40.3 142 27.5
HIV result (Combination T1 + T2)
No 116 90.6 474 95.4
0.037
Yes 12 9.4 23 4.6
Sharing paraphernalia**
No 34 26.4 163 33.3
0.134
Yes 95 73.6 327 66.7
Lifetime use of injection drugs
No 62 48.1 449 87.0
0.000
Yes 67 51.9 67 13.0
Genital ulcer**
No 123 95.3 505 97.9
0.110
Yes 6 4.7 11 2.1
Genital warts**
No 124 96.1 507 98.3
0.137
Yes 5 3.9 9 1.7
Piercing/tattoos
No 48 37.8 226 45.1
0.138
Yes 79 62.2 275 54.9
Oral/gingival sores**
No 75 58.1 272 54.0
0.396
Yes 54 41.9 232 46.0
Table 2. Proportional distribution (%) of HCV-positive and HCV-negative crack users according to 
socioeconomic characteristics, drug use, risk behavior, and STI symptoms. Brazil, 2012. Note: Only considers 
valid cases, does not consider missing values. *p-value from chi-square test. **In the 30 days prior to the 
interview.
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The variables in the multilevel logistic regression model that incorporated uncertainty were the same as in the 
traditional model. However, the odds ratios were higher for all the risk factors in the model that included uncer-
tainty in the outcome (Fig. 1). Notice that in this model the OR can be interpreted as the individual’s likelihood of 
presenting positive HCV infection status. Thus, the model estimated that the odds of an individual being infected 
with the hepatitis C virus were 85% higher in polydrug users, compared to individuals that only used crack plus 
one more illegal drug (OR: 1.85; 95% CI:1.06–3.21). In relation to injection drug use, the odds of positive HCV 
status were 7.81 higher in persons that had used injection drugs any time in life (OR: 8.81; 95% CI:5.40–14.37). 
Self-reported genital ulcers were also associated with the outcome: the odds of HCV infection were 3.69 higher in 
individuals that reported these symptoms (OR: 4.69; 95% CI:1.38–15.92).
Discussion
The study found that crack users are more likely to be exposed to the risk of acquiring HCV if they report lifetime 
injection drug use, polydrug use, and ulcerative STIs. However, corroborating the models described by Magder & 
Huges17, the model in the current study that incorporated uncertainty in the HCV test showed higher estimated 
odds ratios (farther from 1), evidencing that when the test’s uncertainty is not incorporated, the non-differential 
classification error tend to skew the estimates, thus presenting coefficients that tend to be underestimated.
The traditional multilevel logistic regression model assumes that the sensitivity and specificity in the outcome 
variable are 100% (or that the difference from 100% is irrelevant), that is, that there is no uncertainty in the 
observed outcome. This type of error may hinder the detection of associations between the explanatory variables 
and the outcome, since the closer to the null value the estimate is, the lower the risk attributed to it. Additionally, 
the confidence intervals found in the adjusted models with the incorporation of uncertainty are wider than those 
in the traditional model. That is, as expected, the incorporation of uncertainty is directly associated with loss of 
result’s precision (loss of information in favor of greater synchronization with the challenges observed in “real life 
situations”). This can also mean that in the traditional model, the estimated coefficient may display overestimated 
precision, as evidenced by narrower confidence intervals17. Another advantage of the multilevel logistic regres-
sion model, as it incorporates the test’s sensitivity and specificity, is the possibility of estimating the associations 
between the risk factors and infection status itself. In this study, since the sensitivity and specificity values adopted 
for the outcome (HCV test result) can be considered high [93.23% (95% CI: 89.38–96.01) and 99.07% (95% 
CI: 97.32–99.81), respectively], no major change was seen between the estimates generated by the traditional 
model and the model that incorporated uncertainty. We also added the uncertainty associated with the sensitivity 
and specificity values as proper elicited priors in a Bayesian multilevel logistic regression model and no major 
changes were observed. Results comparing all models and different inference approaches were presented in the 
Supplementary Material.
Lifetime injection drug use was the variable most strongly associated with HCV infection, corroborating 
extensive findings in the scientific literature10–12,21 and highlighting the relevance of HCV parenteral transmission. 
A prospective cohort study in three Spanish cities from 2001 to 2003 followed 305 HCV-negative persons 18 to 
30 years of age who used heroin but had never injected the substance and showed that the HCV seroconversion 
rate was 10 times higher in persons that converted to injecting heroin than among those who never injected the 
drug22. Inciardi et al.23 conducted a qualitative study to verify changes in the pattern of cocaine use in southern 
Brazil and found that persons migrated from injecting cocaine to [smoked] crack use, not only because of the 
poor quality of the available powder cocaine (making it hard to dilute and then to inject), but also due to crack’s 
availability and also perhaps the influence of prevention campaigns over the years, emphasizing the risks associ-
ated with injection drug use. Thus, in Brazil today, we measure the impact of past use of injection, rather than a 
putative increase of rare current injection of cocaine24.
Some studies have found an association between length of crack use and increased risk of HCV infection21,25. 
However, in the current study, although the bivariate analysis suggested the relevance of this variable, the asso-
ciation did not remain in the final model. Likewise, no association was found between sharing crack-use para-
phernalia and HCV infection, and no significant difference was identified in the report of this behavior when 
Figure 1. Crude and adjusted odds ratios from the final models for hepatitis C, according to the incorporation 
of the rapid test’s sensitivity and specificity. Brazil, 2012. MLR: Multilevel logistic regression model, MLRwU: 
Multilevel logistic regression model with uncertainty.
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comparing HCV-positive and HCV-negative individuals. Fischer et al.15 conducted a study of 51 crack users 
in Toronto, Canada, with the aim of identifying HCV in the paraphernalia they used to consume the drug. The 
authors identified HCV in a crack pipe with a glass stem (connected to the pipe bowl) and suggested that HCV 
can be transmitted by sharing crack paraphernalia, and that such transmission may be modulated by the pres-
ence/absence of oral sores and the type of paraphernalia used to consume the drug. In Brazil, as shown in the 
National Crack Cocaine Survey26, most crack users recycle industrial plastic cups or bottles to smoke the drug, 
unlike observations in Toronto by Fischer et al.15, where most of the paraphernalia consisted of pipes and similar 
handmade devices. In addition, in the current study, oral and gingival sores were not associated with HCV infec-
tion, even in the bivariate analysis.
Polydrug use has been described in the literature as an important risk factor for HCV transmission, mainly 
in specific populations such as men who have sex with men and injecting drug users27–30. Polydrug use may 
also be associated with other risky practices such as lack of condom use during sexual relations31,32. A cohort 
study in Canada with injecting drug users found an increased risk of HCV infection among polydrug users, 
among individuals that used opioid in combination with cocaine/crack. The authors suggested that this increased 
risk of acquiring HCV results from cocaine’s stimulant effects (whether injected or smoked), which could affect 
decision-making processes, and which could also contribute to the increased risk of HCV transmission through 
shared injection paraphernalia33. The possible role of the combined use of opioids and stimulants is not clear, 
since intense, exclusive use of opioids is sometimes associated with sexual dysfunction34, as opposed to crack 
users’ intense, usually unprotected sexual activity, which may or may not be associated with the sexual trans-
mission of HCV. Sexual transmission of HCV is still controversial35. In the current study, using crack and two or 
more other illegal drugs (other than alcohol and tobacco) was also associated with greater risk of HCV infection, 
suggesting that the concurrent use of different substances exposes the individual to more secondary risk factors 
or to risks with more complex determination (e.g., modulation of sexual behavior by different psychoactive sub-
stances or different patterns of shared use), since different substances can be administered by different routes and 
necessarily have specific physiological effects and associated behaviors, sometimes with synergistic interaction (as 
in the example of secondary metabolites from the simultaneous use of cocaine and alcohol, like cocaethylene36), 
and other times with conflicting or unpredictable effects.
In general, blood (whether contaminated or not) can penetrate the genital epithelium more readily in the 
presence of ulcerations or micro-lacerations. In some circumstances, these small exposures can be sufficient for 
HCV infection37. A study of 1,257 non-injecting drug users who were patients at an STI treatment clinic in 
Baltimore in 1987 found an HCV point prevalence of 9.7%, suggesting that the virus can be transmitted sexually 
in these patients38. Other studies39,40 also point to the possibility of HCV sexual transmission, especially relevant 
for non-injecting drug users (since parenteral exposure tends to confound any other risk factors41,42) with other 
STIs, whether ulcerative or non-ulcerative, such as herpes, gonorrhea, syphilis, and trichomoniasis. The current 
study also found an association between genital ulcer and HCV infection in the study population, which could 
correspond to a cofactor associated with unprotected sexual relations.
Limitations. The article used data from a cross-sectional study. In other words, although it identified risk 
factors statistically associated with HCV infection, it is not possible to establish the directionality of such associ-
ations. The observed outcome, HCV infection, was determined by a single rapid test, and given the nature of the 
virus and its dynamic in the host organism (e.g., the possibility of a partial response and/or gradual establish-
ment), another test with a different methodology is recommended to confirm the diagnosis. Thus, there may be 
persistent classification errors, with false-positives and/or false-negatives. However, by incorporating the uncer-
tainty associated with the diagnostic test into the subsequent models, the findings prove more robust, reinforcing 
their consistency.
Since the primary objective of the Brazilian National Crack Cocaine Survey was not to identify risk factors 
associated with HCV, but to characterize the profile of crack users in open drug use scenes, some of the questions 
used time intervals that are common to other epidemiological surveys (“lifetime use”, “in the last 12 months”, and 
“in the 30 days prior to the interview”), and thus some variables potentially associated with HCV infection could 
not be assessed more comprehensively and precisely (in relation to time). Thus, the results presented here refer to 
crack users 18 years or older who frequently smoked crack in pipes in open scenes (that is, necessarily excluding 
other populations such as users that consume crack in private homes, squatter camps, the prison system, etc.) and 
residing in Brazilian state capitals in 2011–2012.
Other limitation to be considered here refers to the need to match cases and controls by major geographic 
region of the country (macro region), since the matching by state capital proved unfeasible. Brazil is a big, heter-
ogeneous country and the population may differ in some aspects between and within major states. Since all the 
cases were from state capitals and the controls came from different states from the same macro region, they are 
likely differ in some aspects that were not possible to consider in this study.
Conclusion. Our findings highlight the need to invest in harm reduction measures such as needle exchange 
programs where pockets of injection drug users remain active and distribution of condoms and lubricants, which 
can act as barriers to the spread of HCV and other infections classically defined as sexually transmissible. HCV 
infection is mostly asymptomatic, and when the individual does present symptoms the infection is usually estab-
lished and is associated with serious health harms such as cirrhosis and/or liver cancer. To avoid the severe forms 
and deaths resulting from HCV infection requires not only preventive measures but also widely available and 
speedy diagnosis, prompt referral to health services, and guaranteed adequate treatment.
The high efficiency of the new generation of antivirals (directly acting antivirals [DAAD]) make them essen-
tial for both the proper treatment (and eventual cure) of individual patients, as well as to decrease average viral 
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load/infectivity at the population level, as highlighted by the abovementioned strategy endorsed by the WHO, to 
eliminate HCV as of 2030.
Methods
Study Design. The current study carried out a cross-sectional analysis of a subset of the original database 
from the National Crack Cocaine Survey26, a nationwide survey coordinated by the Oswaldo Cruz Foundation 
(FIOCRUZ) of the Brazilian Ministry of Health.
The National Crack Cocaine Survey (PNC, Pesquisa Nacional sobre o Uso de Crack, in Portuguese) aimed 
to describe the profile of crack users (and users of similar coca-derived substances such as freebase, hereinafter 
included under the term “crack users”) in Brazil’s 26 state capitals, Federal District, 9 metropolitan areas, and 
an additional “Brazil” stratum consisting of medium-sized and small municipalities. Time-location sampling 
(TLS)43 was the chosen methodology, which has been applied to studies of hard-to-reach populations26,44. After 
conducting a comprehensive mapping of crack use scenes in the sampled municipalities, scenes, days, and shifts 
were selected for visitation, using inverse sampling in the final selection stage45.
The eligibility criteria was: to be a Brazilian citizen, aged 18 years or older, who had used crack and/or similar 
substances for at least 25 days in the six months prior to the survey, which corresponds to approximately at least 
once a week, according to the CODAR criterion46 in open drug use scenes26. The exclusion criteria comprised 
individuals with severe mental health disorder (include those who were acutely intoxicated at the moment they 
would be interviewed), conditions that may preclude potential interviewees to understand the nature and pur-
pose of the study and to comprehend the informed consent form.
Selected crack use scenes were visited by trained staff, including recruiters and interviewers, mostly health 
professionals. Individuals were approached to eligibility verification by recruiters. Those that met the eligibility 
criteria and signed the free and informed consent form proceeded to answer a questionnaire in a face-to-face 
interview. Interviewers used a pre-tested paper-and-pencil questionnaire. Data were collected in 2011 and 2012, 
and 7,381 persons were interviewed. Additional information about the PNC can be found in the Supplementary 
Material.
Diagnostic testing. After answering the questionnaire, subjects were invited to do an HIV test (Rapid Check 
HIV [screening] and Biomanguinhos [confirmatory]) and an HCV test (WAMA Imuno-Rápido HCV-Kit®). 
Testing was accompanied by the necessary pre and post-counseling and referral for treatment in case of detection 
of infection/disease. Tests and counseling were performed by health professional in accordance to the Brazilian 
Ministry of Health norms.
HCV testing used the rapid immune test produced by Wama Diagnóstica®. Blood samples for the test were 
drawn by fingerstick, according to manufacturer’s instructions. Use of the rapid test aimed to simplify the field 
logistics, streamline the diagnosis and referral to health services, and minimize the biological risks of these proce-
dures (venous puncture in open crack use settings has been associated with operational difficulties and biosafety 
risks). Under laboratory conditions, the test shows high sensitivity and specificity and adequate predictive value, 
as informed by the company that produces the kit and confirmed by the Brazilian health regulatory agency 
(ANVISA).
Selection of study participants. The prevalence of HCV infection in crack users in open scenes in Brazil, 
according to the PNC survey, was 2.63% (95% CI: 1.69–4.07)26.
Considering this prevalence, higher than in the general population but still relatively low from the statistical 
point of view of a large sample, the decision was made to use a case-control study design. Cases were all the 129 
participants with positive results in the rapid test for hepatitis C virus (HCV-POSITIVE), all living in state cap-
itals. For each case, four individuals with negative HCV test results (HCV-) were randomly selected as controls, 
matched by sex, age category (18–30; 31–45, 46+ years), and major geographic region of the country (matching 
by state capital proved unfeasible). Matching by age category aimed to minimize the effect of age cohort or birth 
cohort, since mandatory HCV screening tests in blood banks were implemented systematically in Brazil in the 
1990s47; the matching also attempted to provide a broad balance in exposure time, since exposure to HCV is often 
cumulative and extended over time.
Observed outcome variable. The outcome variable was defined as a “positive” (serologically reactive) result 
in the HCV antibody test, which in the current study was the WAMA Imuno-Rápido HCV-Kit® diagnostic test.
Covariates (Exposure). The study initially considered the following potential risk factors associated with 
hepatitis C infection with available information from the PNC questionnaire: sociodemographic data, including 
race/color (“white”, “black”, “brown’, “indigenous/Asian-descendent”); schooling (“none”, “primary”, “secondary”, 
“university”); type of housing in the 30 days prior to the interview (“some type of fixed housing”, “temporary 
housing”, “homeless”, “other”), and main source of income in the last 30 days (“odd jobs”, “regular formal employ-
ment with benefits”, “illegal activity”, “family/partner”, “sex work”, “begging”).
As for psychoactive substance use, the variable “polydrug use” was created (“use of 1 illegal drug” vs. “use of 2 
or more illegal drugs”). Polydrug use was defined as individual self-report of the use of two or more illegal drugs 
(which included marijuana, cocaine, ecstasy, or amphetamines) in addition to crack in the 12 months prior to the 
study. Alcohol and tobacco were not computed in the composition of the ‘polydrug use’ variable, because they are 
legally sold and used in Brazil and were reported to be used on a regular basis by the vast majority (over 90%) of 
the study subjects26, to the point of losing any discriminatory value. In addition to polydrug use, we also included 
the length of crack use (considered here as a dichotomous variable, i.e., up to 5 years versus more than 5 years); 
lifetime use of injection drugs (“yes” vs. “no”); and having shared crack-use paraphernalia in the 30 days prior to 
the interview (“yes” vs. “no”).
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The following clinical variables were selected: result of the rapid HIV test (“positive” vs. “negative”); report 
of genital ulcer (“yes” vs. “no”); and report of genital warts in the 30 days prior to the interview (“yes” vs. “no”).
Risk behavior factors in the 30 days prior to the interview were: condom use (“did not have sexual relations”, 
“failed to use a condom at least once”, “used condoms in all sexual relations”), trading sex for drugs or money 
(“yes” vs. “no”) and oral and gingival sores (“yes” vs. “no”). Having any tattoos and/or piercing (“yes” vs. “no”) 
was also selected.
As for the inherent context in the open drug use scenes, the model considered the “shift” in which the person 
was recruited at the scene (“morning/afternoon” vs. “night”) and day of the week (“Monday to Thursday” vs. 
“Friday to Sunday”).
Statistical analysis. We calculated the absolute and relative frequencies of the categorical variables poten-
tially associated with the HCV test result. These associations were verified with the chi-square test. Variables with 
statistical significance at p-value ≤25% were included in the regression models, following the suggestion made 
by Sander Greenland’ classic paper on optimal procedures (to be as flexible as possible in every first round) to be 
putatively used in the preliminary assessment of complex datasets and respective modeling strategies48.
The presence of explanatory factors for HCV infection at different levels (individual and contextual) informed 
the choice of multilevel logistic regression models49. The first level is the context to which the subject belongs, 
specifically the time and day of the week at the crack use scene where the individual was recruited. The time of 
day and day of the week in which the individual was recruited were included in the model as random effects, 
based on the hypothesis that the potential associations between the target risk factors and the result of the rapid 
HCV test could differ between individuals that frequent open drug use scenes during different shifts and on dif-
ferent days. Another hierarchical structure was defined by the case-control matching index, defined by a unique 
number attributed to each case and its respective four matched controls according to sex age bracket, and major 
geographic region. The case-control matching index was added into the model as random effects.
HCV infection is represented in this study’s context exclusively by the rapid HCV diagnostic test result, in the 
absence of additional confirmatory diagnostic tests. A diagnostic test’s result is influenced by the kit’s sensitivity 
and specificity, besides the challenges posed by their concrete application under different operational conditions, 
in different contexts and populations (e.g. predominance of given strains after founder effects or uneven geo-
graphic dissemination in given populations or higher variable background infection rates in different popula-
tions)49. There is an abundant literature on kits’ sensitivity and specificity in different contexts and populations in 
a broad sense, but few ones have addressed the simple but anyway challenging issues of their proper conservation, 
use under unfavorable conditions and by people who may lack optimal training or have their skills challenged by 
real-life hurdles such as less-than-optimal conditions to read kits’ results (poor lightning, places under permanent 
pressure imposed by lack of running water, high humidity, etc50.
Thus, in addition to the traditional multilevel logistic modeling, a second set of logistic regression models 
were implemented, incorporating the outcome’s uncertainty (further details available in the web appendix). The 
diagnostic test’s sensitivity and specificity were documented by Scalione et al.49 while assessing its performance in 
diverse contexts. The choice was made to use these values, since the context assessed was closer to that observed 
in our fieldwork than that on the test’s package insert. The study thus considered point estimates of 93.23% for 
sensitivity (95% CI:89.38–96.01) and 99.07% for specificity (95% CI:97.32–99.81)49.
The results of the multilevel logistic regression models with and without incorporation of sensitivity and spec-
ificity values are presented as odds ratios (OR) and respective 95% confidence intervals.
The analyses were performed with the R software package, version 3.4.251. A specific link function was created 
for the multilevel logistic regression model uncertainty in the outcome by providing the sensitivity and specificity. 
The model formulation and the scripts are available in the Supplementary Material.
Ethical approval and informed consent. The study was approved by the Institutional Review Board (IRB) 
of the Sergio Arouca National School of Public Health (ENSP/FIOCRUZ), case review CAAE 0073.0.031.000-11. 
The IRB from ENSP/FIOCRUZ is part of the network CEP-CONEP. All research was performed in accordance 
with international ethical standards. Informed consent was obtained from all participants.
Data Availability
All data generated or analyzed during this study are included in this published article (and its Supplementary 
Information Files).
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